<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">834</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2016-15-4-37-39</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BRIEF REPORT</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">IMMUNOLOGICAL PHENOTYPE OF PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH PRIMARY OPERABLE BREAST CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>ИММУНОФЕНОТИП ЛИМФОЦИТОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ БОЛЬНЫХ ПЕРВИЧНО-ОПЕРАБЕЛЬНЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zabotina</surname><given-names>T. N.</given-names></name><name xml:lang="ru"><surname>Заботина</surname><given-names>Татьяна Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>tatzabotina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korotkova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Короткова</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Hakimova</surname><given-names>Sh. G.</given-names></name><name xml:lang="ru"><surname>Хакимова</surname><given-names>Ш. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Borunova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Борунова</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tabakov</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Табаков</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vorotnikov</surname><given-names>I. K.</given-names></name><name xml:lang="ru"><surname>Воротников</surname><given-names>И. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kadagidze</surname><given-names>Z. G.</given-names></name><name xml:lang="ru"><surname>Кадагидзе</surname><given-names>З. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff><pub-date date-type="pub" iso-8601-date="2016-12-30" publication-format="electronic"><day>30</day><month>12</month><year>2016</year></pub-date><volume>15</volume><issue>4</issue><fpage>37</fpage><lpage>39</lpage><history><date date-type="received" iso-8601-date="2018-04-10"><day>10</day><month>04</month><year>2018</year></date></history><permissions/><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/834">https://bioterapevt.abvpress.ru/jour/article/view/834</self-uri><abstract xml:lang="en"><p>Objecive. The investigation is devoted to study subpopulation structure of lymphocytes from peripheral blood of patients, suffering from breast cancer. Materials and methods. Peripheral blood of 70 patients with breast cancer and 39 healthy women was analyzed using the flow cytometry method with monoclonal antibodies to CD3, CD4, CD8, CD16, CD56, CD19, CD45 antigens. Results. Statistically significant disturbance of linear structure of lymphocytes (T-cells CD45+/CD3+/CD19-; B-cells CD45+/CD3-/ CD19+; NK-cells CD45+CD3-CD16+56+) detected only in the analysis of individual immunograms, but not in analysis of whole group of breast cancer patients. Conclusion. Based on analysis of frequence of occurrence of disturbances of cancer breast patients with low values of ratio CD4/CD8, it was detected 4 different variants of disturbance.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования - изучение субпопуляционной структуры лимфоцитов периферической крови первичных больных раком молочной железы. Материалы и методы. С помощью многопараметрового проточно-цитометрического анализа исследовали периферическую кровь 70 первичных больных раком молочной железы и 39 здоровых женщин. Использовали моноклональные антитела к антигенам CD3, CD4, CD8, CD16, CD56, CD19, CD45. Результаты. Статистически достоверное нарушение линейной структуры лимфоцитов - Т-клеток с фенотипом CD45+/ CD3+/CD19<sup>-</sup>, В-лимфоцитов с фенотипом CD45+/CD3<sup>-</sup>/CD19+ и NK-лимфоцитов с фенотипом CD45+/CD3<sup>-</sup>/CD16+56+ - выявляется только при анализе индивидуальных иммунограмм, но не при анализе всей группы больных раком молочной железы. Заключение. На основе анализа частоты встречаемости нарушений среди больных раком молочной железы с низкими показателями соотношения CD4/CD8 определены 4 различных варианта нарушений.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммунологический фенотип лимфоцитов</kwd><kwd>проточная цитометрия</kwd><kwd>рак молочной железы</kwd><kwd>Immunological phenotype of lymphocytes</kwd><kwd>flow cytometry</kwd><kwd>breast cancer</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hadden J.W. The immunology and immunotherapy of breast cancer: An update. Int J Immunopharmacol 1999;21:79-101. PMID:10230872.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Yi Huang, Chunling Ma, Qunyuan Zhang et al. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. Oncotarget 2015;6(19):17462-78. DOI: 10.18632/oncotarget.3958. PMID: 25968569.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Короткова О.В., Заботина Т.Н., Скотаренко Л.В. и др. Субпопуляции лимфоцитов периферической крови больных РМЖ. Российский биотерапевтический журнал 2011;10(3):95-8.</mixed-citation></ref></ref-list></back></article>
